|Home | About | Journals | Submit | Contact Us | Français|
Jay W. Fox, Ph.D. Dr. Fox received his B.A. in Philosophy and Chemistry from Monmouth College, in 1974, and his Ph.D. in Biochemistry in 1978 from Colorado State University working with Dr. Anthony T. Tu at CSU and Dr. Marshall Elzinga at Brookhaven National Laboratory. He was a post-doctoral fellow with Dr. John Stewart at the University of Colorado, School of Medicine. In 1981, Dr. Fox joined the faculty of the Department of Microbiology at the University of Virginia where he established the Biomolecular Research Facility that he directs. In 1991 Dr. Fox was promoted to Professor of Microbiology and in 1999 he was named Assistant Dean for Research. Dr. Fox is Assistant Director for Laboratory Research of the UVa Cancer Center. He has served on numerous NIH and NSF review panels, including the NCRR Shared Instrumentation Grant Program and the NSF Shared Instrumentation/Instrument Development Program. He has been associated with ABRF since its inception and has been a member of the Amino Acid Analysis and the Nucleic Acids Research Groups. He currently serves ABRF as a chairman of the Travel Award Committee. Dr. Fox is also a founding member of the International Association of Protein Structure Analysis and Proteomics and is a member of its executive board. Recently Dr. Fox was named to the National Center for Research Resources (NCRR) Strategic Planning Committee charged with developing the next five-year program for the NCRR.
David Landsman, Ph.D. Chief of the Computational Biology Branch of the National Center for Biotechnology Information (NCBI), a division of the National Library of Medicine at the National Institutes of Health, Bethesda, Maryland. He has been a member of ABRF since 1999. He received his Ph.D. degree from the Biochemistry Department at the University of Cape Town, South Africa in 1984. He was as a postdoctoral fellow at the National Cancer Institute before taking a position at the NCBI, an informatics resource supplying information to scientists worldwide about the biomedical literature (Pub Med), DNA and protein sequences (GenBank), and several genome related topics. He has several years of bench science experience as well as expertise in the application of computational tools to biological problems and in bioinformatics. His current research area is the computational analysis of the proteins involved in chromatin structure and gene regulation. He is interested in developing new methods to extract information from gene regulatory regions in genomic DNA and from micro array data. Dr. Landsman teaches computational biology to graduate students at Johns Hopkins University. He has participated actively in ABRF functions for a number of years and was co-organizer of the ABRF1999 annual meeting in Durham, North Carolina. He is currently the Chair of the ABRF Education Committee.
Kathryn S. Lilley, Ph.D. Facility Group Leader, Cambridge Centre for Proteomics, Department of Biochemistry, University of Cambridge, UK. She has been a member of ABRF since 1995. She received her Ph.D. in Biochemistry from the University of Sheffield in 1990. She ran a Protein and Nucleic Acid Laboratory core facility at the University of Leicester for 11 years, initially starting with Edman degradation, DNA synthesis and HPLC core services and adding peptide synthesis, DNA sequencing and both MALDI-TOF and LC-MS mass spectrometry facilities during this period and assisting in the creation of a cDNA microarray laboratory. Since November 2000, she has established the Cambridge Center for Proteomics (CCP) of which she is facility director at the University of Cambridge. This state-of-the-art center provides core proteomics services for the UK Arabidopsis and Drosophila communities and collaborates with a large number of groups in the UK and worldwide. The research focus of her group includes development of methods in quantitative proteomics, especially of complex membrane fractions, and analysis methodologies within comparative proteomics. The group also collaborates with transcriptomics facilities and bioinformaticians on large-scale system biology approaches. She has sat on several committees advising UK funding bodies on the future needs of the proteomics community. During her ABRF membership she has been an active and enthusiastic member of the NARG (1998–2001) and DSRG (1999) and was a founding member of the MARG (2000–2002). She has recently organized sessions at the International Mass Spectrometry meeting on behalf of ABRF.
Andrew Brooks, Ph.D. Dr. Brooks is Director of the Functional Genomics Center at the University of Rochester Medical Center. He received his doctoral degree from the University of Rochester and currently holds an appointment in Environmental Medicine as an Assistant Professor. Dr. Brooks’ laboratory has three main areas of interest. First, his group works on deciphering the molecular mechanisms that underlie memory and learning. They utilize a variety of technologies for genetic modification as well as investigate gene–environment interactions in the context of aging, neurodegenerative disease and neurotoxicant exposure. Their research utilizes many high-throughput genomics based technologies to study these areas. Second, his group is involved in the development of novel informatics approaches to better understand complex genomics-based data sets. The team has recently developed a novel method for interpreting complex gene expression data sets as a function of biological relevance. This approach is being utilized both in the basic science and clinical arenas. Lastly, Dr. Brooks’ team is engaged in a number of technology development programs. Currently, they are developing new applications in the area of transcript profiling and protein profiling that can be applied to both standard and novel technology platforms. More recently Dr. Brooks has been appointed Director of the AMDeC Microarray Resource Center, which helps coordinate all micro array and genomics related activities for New York State. Dr. Brooks has been actively involved with ABRF for a number of years and currently chairs the Microarray Research Group.